Valeant Pharmaceuticals International Marks World Sight Day at the NYSE

Multinational pharmaceutical company, Valeant Pharmaceuticals International, Inc. (NYSE: VRX), led by Executive Vice President and CFO Howard Schiller and other members of the company’s leadership team, will visit the New York Stock Exchange and ring The Closing Bell® to highlight World Sight Day.
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology and branded generics.  More information about Valeant can be found at (Source: Valeant)
World Sight Day (WSD) is an annual day of awareness held on the second Thursday of October, to focus global attention on blindness and vision impairment. While our Bausch + Lomb colleagues spend every day of the year helping people see better to live better, World Sight Day provides a unique global platform for us to remind people about the importance of getting regular eye exams, maintaining a diet rich in such nutrients as Lutein and Zeaxanthin, and taking other steps to protect their vision and overall eye health.